These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 27796698)

  • 21. MiR-100-3p and miR-877-3p regulate overproduction of IL-8 and IL-1β in mesangial cells activated by secretory IgA from IgA nephropathy patients.
    Liang Y; Zhao G; Tang L; Zhang J; Li T; Liu Z
    Exp Cell Res; 2016 Oct; 347(2):312-21. PubMed ID: 27542871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-320 promotes B cell proliferation and the production of aberrant glycosylated IgA1 in IgA nephropathy.
    Li C; Shi J; Zhao Y
    J Cell Biochem; 2018 Jun; 119(6):4607-4614. PubMed ID: 29266359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased number of Th22 cells and correlation with Th17 cells in peripheral blood of patients with IgA nephropathy.
    Peng Z; Tian J; Cui X; Xian W; Sun H; Li E; Geng L; Zhang L; Zhao P
    Hum Immunol; 2013 Dec; 74(12):1586-91. PubMed ID: 23978338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-17 promotes the production of underglycosylated IgA1 in DAKIKI cells.
    Lin JR; Wen J; Zhang H; Wang L; Gou FF; Yang M; Fan JM
    Ren Fail; 2018 Nov; 40(1):60-67. PubMed ID: 29299950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of C1GALT1C1 in lipopolysaccharide-induced IgA1 aberrant O-glycosylation in IgA nephropathy.
    Xie LS; Qin W; Fan JM; Huang J; Xie XS; Li Z
    Clin Invest Med; 2010 Feb; 33(1):E5-13. PubMed ID: 20144270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased cytokine-induced IgA subclass production by CD40-ligated circulating B cells in primary IgA nephropathy.
    de Fijter JW; van Nisselrooij NI; Schroeijers WE; Daha MR; van Es LA; van Kooten C
    Nephrol Dial Transplant; 1998 Feb; 13(2):285-92. PubMed ID: 9509436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COSMC expression as a predictor of remission in IgA nephropathy.
    Akgul SU; Cinar CK; Caliskan Y; Demir E; Cebeci E; Meral R; Temurhan S; Ozluk Y; Aydin F; Oguz FS
    Int Urol Nephrol; 2023 Apr; 55(4):1033-1044. PubMed ID: 36306048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No evidence for a role of cosmc-chaperone mutations in European IgA nephropathy patients.
    Malycha F; Eggermann T; Hristov M; Schena FP; Mertens PR; Zerres K; Floege J; Eitner F
    Nephrol Dial Transplant; 2009 Jan; 24(1):321-4. PubMed ID: 18840896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Regulatory effects of yiqi zishen granule on helper T-lymphocyte subsets in IgA nephropathy patients].
    Yu DJ; Nie LF; Xu YG
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Sep; 26(9):836-8. PubMed ID: 17058837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of levels of Toll like receptor-4 in monocytes, CD4+ T-lymphocyte subsets, and cytokines in patients with immune thrombocytopenic purpura.
    Liu H; Ouyang X; Li Y; Zeng H; Wang X; Xie S; Nie D; Xiao J; Wei J; Wu Y; Yin S; Ma L
    Thromb Res; 2013 Aug; 132(2):196-201. PubMed ID: 23830211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. microRNA-630 Regulates Underglycosylated IgA1 Production in the Tonsils by Targeting TLR4 in IgA Nephropathy.
    Liu C; Ye MY; Yan WZ; Peng XF; He LY; Peng YM
    Front Immunol; 2020; 11():563699. PubMed ID: 33324395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic characterization of cytokine expression in patients with IgA nephropathy.
    Yano N; Endoh M; Nomoto Y; Sakai H; Fadden K; Rifai A
    J Clin Immunol; 1997 Sep; 17(5):396-403. PubMed ID: 9327339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy.
    Xu LX; Zhao MH
    Kidney Int; 2005 Jul; 68(1):167-72. PubMed ID: 15954905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of regulatory T cell subsets in the peripheral blood of immunoglobulin A nephropathy (IgAN) patients.
    Yang S; Chen B; Shi J; Chen F; Zhang J; Sun Z
    Genet Mol Res; 2015 Oct; 14(4):14088-92. PubMed ID: 26535723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulated Expression of microRNA-16 Correlates with Th17/Treg Cell Imbalance in Patients with Rheumatoid Arthritis.
    Wu YH; Liu W; Xue B; Zhang L; Liu XY; Liu B; Wang Y; Cai Y; Duan R
    DNA Cell Biol; 2016 Dec; 35(12):853-860. PubMed ID: 27875659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated hsa-miR-590-3p expression down-regulates HMGB2 expression and contributes to the severity of IgA nephropathy.
    Zhai Y; Qi Y; Long X; Dou Y; Liu D; Cheng G; Xiao J; Liu Z; Zhao Z
    J Cell Mol Med; 2019 Nov; 23(11):7299-7309. PubMed ID: 31557418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TLR9 and BAFF: their expression in patients with IgA nephropathy.
    Li W; Peng X; Liu Y; Liu H; Liu F; He L; Liu Y; Zhang F; Guo C; Chen G; Zhang L; Dong Z; Peng Y
    Mol Med Rep; 2014 Sep; 10(3):1469-74. PubMed ID: 24993857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant galactosylation of IgA1 is involved in the genetic susceptibility of Chinese patients with IgA nephropathy.
    Lin X; Ding J; Zhu L; Shi S; Jiang L; Zhao M; Zhang H
    Nephrol Dial Transplant; 2009 Nov; 24(11):3372-5. PubMed ID: 19531670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression profile of Fc receptor-like molecules in patients with IgA nephropathy.
    Zhong Z; Shi D; Xiao M; Fu D; Feng S; Kong Q; Li J; Li Z
    Hum Immunol; 2021 Mar; 82(3):186-192. PubMed ID: 33597097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA‑196b targets COSMC in pediatric IgA nephropathy.
    Sun Q; Lan J; Zhang H; Zhou N; Liang Y; Liu X
    Mol Med Rep; 2020 May; 21(5):2260-2266. PubMed ID: 32186752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.